You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 12, June 25, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal

Consensus Needed for Evaluating Safe and Adequate Anticoagulant Control

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the recent article by Fitzmaurice et al.1 The primary outcome they reported was the point prevalence of patients achieving individual therapeutic international normalized ratio (INR) targets. Although the authors state that this method is routinely used in England, there is no clear consensus. In an attempt to standardize the evaluation of anticoagulant control, the INR was introduced, and disease-specific INR target ranges were recommended.

In recent years, a variety of methods have been used to evaluate therapeutic control of the INR in England and elsewhere. Some of the most widely used methods include the following: (1) the proportion of INRs within target ranges2; (2) the proportion of time spent within the individual target ranges3; (3) the proportion of INRs within the target range ± 10%4; and (4) the mean ± 1 SD INR for the clinic overall.5

There have been no recommendations for . . . [Full Text of this Article]


RELATED ARTICLE

Oral Anticoagulation Management in Primary Care With the Use of Computerized Decision Support and Near-Patient Testing: A Randomized, Controlled Trial
David A. Fitzmaurice, F. D. Richard Hobbs, Ellen T. Murray, Roger L. Holder, Teresa F. Allan, and Peter E. Rose
Arch Intern Med. 2000;160(15):2343-2348.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chronic unexplained fatigue * Author's reply
Baschetti
Postgrad. Med. J. 2002;78:763-763.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.